Stockreport

Athersys: A Lucrative China Stem Cell Licensing Deal Seems Imminent [Seeking Alpha]

Athersys, Inc.  (ATHX) 
Last athersys, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: athersys.com/press-releases
PDF Athersys: A Lucrative China Stem Cell Licensing Deal Seems ImminentSummaryAthersys files 8-K extending Healios K.K.'s right of first refusal deadline by one week to Dece [Read more]